+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Diagnosis (Laboratory Tests, Imaging Tests); Indication (Pain and Cramping, Diarrhea, Constipation, Alternating Constipation and Diarrhea), and Geography

  • ID: 5314025
  • Report
  • March 2021
  • Region: Global
  • The Insight Partners
UP TO OFF
until Jan 15th 2022

FEATURED COMPANIES

  • Aerodiagnostics, LLC.
  • Biohit Oyj
  • BÜHLMANN Laboratories AG.
  • Gemelli Biotech
  • Genova Diagnostics
  • Inova Diagnostics, Inc.
  • MORE
The global irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5.80% from 2020 to 2028.



Increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics developments are the factors driving the global irritable bowel syndrome (IBS) diagnostics market. However, the challenges in diagnosis of IBS are hindering the market growth.

Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test, and stool test. The tests are done based on symptoms such as constipation-predominant, diarrhea-predominant, or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy, and colonoscopy.

Irritable bowel syndrome is a chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. The disease is also known as spastic colon, irritable colon, mucous colitis, and spastic colitis. Irritable bowel syndrome shows symptoms such as abdominal pain, constipation, diarrhea, and cramping.

People across the world are witnessing considerable incidence of irritable bowel syndrome. According to the data published by International Foundation for Gastrointestinal Disorders, among all irritable bowel syndrome patients, about 40% of people have mild IBS, around 35% have moderate IBS, and an estimated 25% have severe IBS. Food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. According to a study published on NCBI in 2018, irritable bowel syndrome is estimated to affect around 10–16% of the US population each year. Further, as per the IBS Global Impact Report, in 2016, an estimated mean prevalence of individual countries ranged from 1.1% in France and Iran to 35.5% in Mexico. Latin America had a prevalence rate of 17.5%, Asia 9.6%, North America/Europe/Australia/New Zealand 7.1%, and the Middle East & Africa had a prevalence rate of 5.8%. Such staggering prevalence of irritable bowel syndrome is likely to boost the irritable bowel syndrome (IBS) diagnostics market during the forecast period.

Diagnosis Insights

Based on diagnosis, the global irritable bowel syndrome (IBS) diagnostics market is segmented into laboratory tests and imaging tests. In 2020, the laboratory tests segment held the largest share in the market. Moreover, the segment is expected to hold the largest market share by 2028. The market growth is mainly attributed to the growing prevalence of irritable bowel syndrome (IBS) worldwide, which is likely to continue in the coming years due to disturbances in bowel habits and abdominal pain. This, in turn, is boosting the demand for diagnosis of these diseases worldwide.

Indication Insights

Based on indication, the global irritable bowel syndrome (IBS) diagnostics market is segmented into pain and cramping, diarrhea, constipation, and alternating constipation and diarrhea. The pain and cramping segment held the largest market share in 2020, and it is further expected to dominate the market by 2028. Antispasmodics and antidepressants are medication used to treat IBS pain and cramping.

Major primary and secondary sources referred to while preparing the report on the global irritable bowel syndrome (IBS) diagnostics market are the Food and Drug Administration (FDA), National Center for Biotechnology Information (NCBI), American Society for Gastrointestinal Endoscopy, International Foundation for Gastrointestinal Disorders, World Journal of Gastroenterology, International Foundation for Gastrointestinal Disorders, Inc. (IFFGD), Canadian Digestive Health Foundation, Gastrointestinal Society, and The Korean Society of Neurogastroenterology and Motility, among others.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aerodiagnostics, LLC.
  • Biohit Oyj
  • BÜHLMANN Laboratories AG.
  • Gemelli Biotech
  • Genova Diagnostics
  • Inova Diagnostics, Inc.
  • MORE

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market - By Diagnosis
1.3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market - By Indication
1.3.3 Global Irritable Bowel Syndrome (IBS) Diagnostics Market- By Geography

2. Irritable Bowel Syndrome (IBS) Diagnostics Market- Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Irritable Bowel Syndrome (IBS) Diagnostics Market- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 APAC PEST Analysis
4.2.4 MEA PEST Analysis
4.2.5 SCAM PEST Analysis
4.3 Expert Opinion

5. Irritable Bowel Syndrome (IBS) Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions
5.1.2 Increasing number of FDA approvals and diagnostics developments
5.2 Market Restraint
5.2.1 Challenges in Diagnosis of IBS
5.3 Market Opportunity
5.3.1 Increasing disposable incomes of the population
5.4 Future Trend
5.4.1 Development of medical devices for the diagnosis of irritable bowel syndrome
5.5 Impact analysis

6. Irritable Bowel Syndrome (IBS) Diagnostics Market- Global Analysis
6.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Forecast and Analysis
6.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis- by Diagnosis
7.1 Overview
7.2 Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)
7.3 Laboratory Tests
7.3.1 Overview
7.3.2 Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.3.3 Lactose Intolerance Tests
7.3.3.1 Overview
7.3.3.2 Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.3.4 Breath Test for Bacterial Overgrowth
7.3.4.1 Overview
7.3.4.2 Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.3.5 Stool Tests
7.3.5.1 Overview
7.3.5.2 Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.3.6 Blood Tests
7.3.6.1 Overview
7.3.6.2 Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
7.4.1 Overview
7.4.2 Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4.3 CT-Scan or X-Ray
7.4.3.1 Overview
7.4.3.2 CT-Scan or X-Ray: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4.4 Upper Endoscopy
7.4.4.1 Overview
7.4.4.2 Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
7.4.5 Colonoscopy
7.4.5.1 Overview
7.4.5.2 Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

8. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis - By Indication
8.1 Overview
8.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)
8.3 Pain and Cramping
8.3.1 Overview
8.3.2 Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Diarrhea
8.4.1 Overview
8.4.2 Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Constipation
8.5.1 Overview
8.5.2 Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Alternating Constipation and Diarrhea
8.6.1 Overview
8.6.2 Alternating Constipation and Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)

9. Irritable Bowel Syndrome (IBS) Diagnostics Market Analysis and Forecasts To 2028 - Geographical Analysis
9.1 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market
9.1.1 Overview
9.1.2 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.3 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.1.3.1 North America: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.3.2 North America: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.4 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, By Indication - Revenue and Forecast to 2028 (USD Million)
9.1.5 North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
9.1.6 US: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.6.1 US: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.6.2 US: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis- Revenue and Forecast to 2028 (USD Million)
9.1.6.2.1 US: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2 US: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.6.3 US: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication- Revenue and Forecast to 2028 (USD Million)
9.1.7 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.7.1 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.7.2 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis- Revenue and Forecast to 2028 (USD Million)
9.1.7.2.1 Canada: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 Canada: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.1.8 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.8.1 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.1.8.2 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.1.8.2.1 Mexico: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2 Mexico: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.2 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market
9.2.1 Overview
9.2.2 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.3 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.2.3.1 Europe: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.3.2 Europe: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.4 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.2.5 Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028(%)
9.2.6 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.6.1 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.6.2 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.2.6.2.1 Germany: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.6.2.2 Germany: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.6.3 Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.2.7 France: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.7.1 France: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.7.2 France: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.2.7.2.1 France: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.7.2.2 France: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.7.3 France: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.2.8 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.8.1 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.8.2 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.2.8.2.1 UK: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.8.2.2 UK: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.8.3 UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.2.9 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.9.1 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.9.2 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.2.9.2.1 Italy: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.9.2.2 Italy: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.9.3 Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.2.10 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.10.1 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.10.2 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.2.10.2.1 Spain: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.10.2.2 Spain: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.10.3 Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.2.11 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.11.1 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.2.11.2 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.2.11.2.1 Rest of Europe: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.11.2.2 Rest of Europe: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.2.11.3 Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)0
9.3 Asia Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market
9.3.1 Overview
9.3.2 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.3 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.3.3.1 Asia-Pacific: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.3.3.2 Asia-Pacific: Imaging Tests Market, by Type, 2019-2028 (USD Million)
9.3.4 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.3.5 Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
9.3.6 China: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.6.1 China: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.6.2 China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.3.6.2.1 China: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.3.6.2.2 China: Imaging Tests Market, by Type, 2019-2028 (USD Million)
9.3.6.3 China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.3.7 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.7.1 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.7.2 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.3.7.2.1 Japan: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.3.7.2.2 Japan: Imaging Tests Market, by Type, 2019-2028 (USD Million)
9.3.7.3 Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.3.8 India: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.8.1 India: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.8.2 India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.3.8.2.1 India: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.3.8.2.2 India: Imaging Tests Market, by Type, 2019-2028 (USD Million)
9.3.8.3 India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.3.9 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.9.1 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.9.2 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.3.9.2.1 Australia: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.3.9.2.2 Australia: Imaging Tests Market, by Type, 2019-2028 (USD Million)
9.3.9.3 Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.3.10 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.10.1 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.10.2 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.3.10.2.1 South Korea: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.3.10.2.2 South Korea: Imaging Tests Market, by Type, 2019-2028 (USD Million)
9.3.10.3 South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.3.11 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.11.1 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.3.11.2 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis, 2019-2028 (USD Million)
9.3.11.2.1 Rest of Asia-Pacific: Laboratory Tests Market, by Type, 2019-2028 (USD Million)
9.3.11.2.2 Rest of Asia-Pacific: Imaging Tests Market, by Type, by Imaging Tests, 2019-2028 (USD Million)
9.3.11.3 Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication, 2019-2028 (USD Million)
9.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market
9.4.1 Overview
9.4.2 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.3 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.4.3.1 Middle East and Africa: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.3.2 Middle East and Africa: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.4.5 Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
9.4.6 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.6.1 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.6.2 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.4.6.2.1 Saudi Arabia: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.6.2.2 Saudi Arabia: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.6.3 Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.4.7 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.7.1 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.7.2 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.4.7.2.1 South Africa: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.7.2.2 South Africa: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.7.3 South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.4.8 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.8.1 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.8.2 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.4.8.2.1 UAE: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.8.2.2 UAE: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.8.3 UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.4.9 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.9.1 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.4.9.2 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.4.9.2.1 Rest of Middle East and Africa: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.9.2.2 Rest of Middle East and Africa: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.4.9.3 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.5 South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market
9.5.1 Overview
9.5.2 South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.3 South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.5.3.1 South And Central America: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5.3.2 South And Central America: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5.4 South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.5.5 South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
9.5.6 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.6.1 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.6.2 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.5.6.2.1 Brazil: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5.6.2.2 Brazil: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5.6.3 Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.5.7 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.7.1 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.7.2 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.5.7.2.1 Argentina: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5.7.2.2 Argentina: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5.7.3 Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
9.5.8 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.8.1 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
9.5.8.2 Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
9.5.8.2.1 Rest of South And Central America: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5.8.2.2 Rest of South And Central America: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
9.5.8.3 Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)

10. Impact of COVID-19 Pandemic on Global Irritable Bowel Syndrome (IBS) Diagnostics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

11. Irritable Bowel Syndrome (IBS) Diagnostics Market- Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview

12. Company Profiles
12.1 Commonwealth Diagnostics International
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Genova Diagnostics
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Gemelli Biotech
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Prometheus Laboratories
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Inova Diagnostics, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Biohit Oyj
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Aerodiagnostics, LLC.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Metabolic Solutions, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Sysmex Corporation (Sysmex Europe GmbH)
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BÜHLMANN Laboratories AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

List of Tables
Table 1. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 2. North America: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 3. North America: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, By Indication - Revenue and Forecast to 2028 (USD Million)
Table 5. US: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis- Revenue and Forecast to 2028 (USD Million)
Table 6. US: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 7. US: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 8. US: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication-Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis- Revenue and Forecast to 2028 (USD Million)
Table 10. Canada: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 18. Europe: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 19. Europe: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 20. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 21. Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 22. Germany: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 23. Germany: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 24. Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 25. France: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 26. France: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 27. France: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 28. France: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 29. UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 30. UK: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 31. UK: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 32. UK: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 33. Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 34. Italy: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 35. Italy: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 36. Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 37. Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 38. Spain: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 39. Spain: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 40. Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 42. Rest of Europe: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 43. Rest of Europe: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 44. Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 45. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 46. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 47. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)
Table 48. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 49. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 50. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 51. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)
Table 52. China: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 53. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 54. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 55. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)
Table 56. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 57. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 58. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 59. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)
Table 60. India: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 61. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 62. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 63. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)
Table 64. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 65. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 66. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 67. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)
Table 68. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Laboratory Tests - Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Imaging Tests - Revenue and Forecast to 2028 (USD Million)
Table 72. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Indication - Revenue and Forecast to 2028 (USD Million)
Table 73. Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 74. Middle East and Africa: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 75. Middle East and Africa: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 76. Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 77. Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 78. Saudi Arabia: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 79. Saudi Arabia: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 80. Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 81. South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 82. South Africa: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 83. South Africa: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 84. South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 85. UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 86. UAE: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 87. UAE: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 88. UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Middle East and Africa: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 91. Rest of Middle East and Africa: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 92. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 93. South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 94. South And Central America: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 95. South And Central America: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 96. South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 97. Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 98. Brazil: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 99. Brazil: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 100. Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 101. Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 102. Argentina: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 103. Argentina: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 104. Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis - Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of South And Central America: Laboratory Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 107. Rest of South And Central America: Imaging Tests Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 108. Rest of South And Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, Indication - Revenue and Forecast to 2028 (USD Million)
Table 109. Organic Developments Done By Companies
Table 110. Inorganic Developments Done By Companies
Table 111. Glossary of Terms, Irritable Bowel Syndrome (IBS) Diagnostics Market

List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Diagnostics Market Segmentation
Figure 2. Irritable Bowel Syndrome (IBS) Diagnostics Segmentation, By Region
Figure 3. Global Irritable Bowel Syndrome (IBS) Diagnostics Market Overview
Figure 4. Laboratory Tests Systems Held Largest Share of Diagnosis Segment in Irritable Bowel Syndrome (IBS) Diagnostics Market
Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
Figure 6. Irritable Bowel Syndrome (IBS) Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Irritable Bowel Syndrome (IBS) Diagnostics Market- Leading Country Markets (US$ Million)
Figure 8. Global Irritable Bowel Syndrome (IBS) Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. APAC: PEST Analysis
Figure 12. MEA: PEST Analysis
Figure 13. SCAM: PEST Analysis
Figure 14. Irritable Bowel Syndrome (IBS) Diagnostics Market Impact Analysis of Driver and Restraints
Figure 15. Global Irritable Bowel Syndrome (IBS) Diagnostics Market- Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global Irritable Bowel Syndrome (IBS) Diagnostics Market- By Geography Forecast and Analysis - 2020- 2028
Figure 17. Market Positioning of Key Players in Global Irritable Bowel Syndrome (IBS) Diagnostics Market
Figure 18. Irritable Bowel Syndrome (IBS) Diagnostics Market, by Diagnosis 2020 & 2028 (%)
Figure 19. Laboratory Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Lactose Intolerance Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Breath Test for Bacterial Overgrowth: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Stool Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Blood Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Imaging Tests: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. CT-Scan or X-Ray: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Upper Endoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Colonoscopy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue Share, by Diagnosis (2020 and 2028)
Figure 29. Pain and Cramping: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Constipation: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Alternating Constipation and Diarrhea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country - Revenue (2020) (USD Million)
Figure 34. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 35. North America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 36. US: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 37. Canada: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 38. Mexico: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 39. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country - Revenue (2020) (USD Million)
Figure 40. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 41. Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 42. Germany: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. France: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. UK: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Italy: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. Spain: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 47. Rest of Europe: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 48. Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country - Revenue (2020) (USD Million)
Figure 49. Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2027 (USD Million)
Figure 50. Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 51. China: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 52. Japan: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 53. India: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 54. Australia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 55. South Korea: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 56. Rest of Asia-Pacific: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 57. Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country - Revenue (2020) (USD Million)
Figure 58. Middle East and Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2027 (USD Million)
Figure 59. Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 60. Saudi Arabia: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 61. South Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 62. UAE: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 63. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 64. South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Key Country - Revenue (2020) (USD Million)
Figure 65. South and Central America Irritable Bowel Syndrome (IBS) Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 66. South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market, by Country, 2020 & 2028 (%)
Figure 67. Brazil: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 68. Argentina: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 69. Rest of South and Central America: Irritable Bowel Syndrome (IBS) Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 70. Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in North American Countries
Figure 71. Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in European Countries
Figure 72. Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in Asia Pacific Countries
Figure 73. Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in Rest of the World
Figure 74. Impact of COVID-19 Pandemic on Irritable Bowel Syndrome (IBS) Diagnostics Market in Rest of the World
Figure 75. Growth Strategies Done by the Companies in the Market, (%)

Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Commonwealth Diagnostics International
  • Genova Diagnostics
  • Gemelli Biotech
  • Prometheus Laboratories
  • Inova Diagnostics, Inc.
  • Biohit Oyj
  • Aerodiagnostics, LLC.
  • Metabolic Solutions, Inc.
  • Sysmex Corporation
  • BÜHLMANN Laboratories AG.
Note: Product cover images may vary from those shown
Adroll
adroll